These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 14971887)

  • 1. Sabadinine: a potential non-peptide anti-severe acute-respiratory-syndrome agent identified using structure-aided design.
    Toney JH; Navas-Martín S; Weiss SR; Koeller A
    J Med Chem; 2004 Feb; 47(5):1079-80. PubMed ID: 14971887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Broad Spectrum Inhibitors of the Coronavirus 3CLpro: A Virtual Screening and Structure-Based Drug Design Study.
    Berry M; Fielding BC; Gamieldien J
    Viruses; 2015 Dec; 7(12):6642-60. PubMed ID: 26694449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-covalent inhibitors of rhinovirus 3C protease.
    Baxter A; Chambers M; Edfeldt F; Edman K; Freeman A; Johansson C; King S; Morley A; Petersen J; Rawlins P; Spadola L; Thong B; Van de Poël H; Williams N
    Bioorg Med Chem Lett; 2011 Jan; 21(2):777-80. PubMed ID: 21183345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database.
    Desai PV; Patny A; Sabnis Y; Tekwani B; Gut J; Rosenthal P; Srivastava A; Avery M
    J Med Chem; 2004 Dec; 47(26):6609-15. PubMed ID: 15588096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel falcipain-2 inhibitors as potential antimalarial agents through structure-based virtual screening.
    Li H; Huang J; Chen L; Liu X; Chen T; Zhu J; Lu W; Shen X; Li J; Hilgenfeld R; Jiang H
    J Med Chem; 2009 Aug; 52(15):4936-40. PubMed ID: 19586036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory.
    Desai PV; Patny A; Gut J; Rosenthal PJ; Tekwani B; Srivastava A; Avery M
    J Med Chem; 2006 Mar; 49(5):1576-84. PubMed ID: 16509575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.
    Anand K; Ziebuhr J; Wadhwani P; Mesters JR; Hilgenfeld R
    Science; 2003 Jun; 300(5626):1763-7. PubMed ID: 12746549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
    Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
    Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and discovery of novel non-peptide inhibitor of Caspase-3 using ligand based and structure based virtual screening approach.
    Lakshmi PJ; Kumar BV; Nayana RS; Mohan MS; Bolligarla R; Das SK; Bhanu MU; Kondapi AK; Ravikumar M
    Bioorg Med Chem; 2009 Aug; 17(16):6040-7. PubMed ID: 19631549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncovering false positives on a virtual screening search for cruzain inhibitors.
    Malvezzi A; de Rezende L; Izidoro MA; Cezari MH; Juliano L; do Amaral A
    Bioorg Med Chem Lett; 2008 Jan; 18(1):350-4. PubMed ID: 17981033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent antiviral strategies against human coronavirus-related respiratory illnesses.
    Golda A; Pyrc K
    Curr Opin Pulm Med; 2008 May; 14(3):248-53. PubMed ID: 18427249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agents.
    Karypidou K; Ribone SR; Quevedo MA; Persoons L; Pannecouque C; Helsen C; Claessens F; Dehaen W
    Bioorg Med Chem Lett; 2018 Nov; 28(21):3472-3476. PubMed ID: 30286952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of small molecule inhibitors of ubiquitin-like poxvirus proteinase I7L using homology modeling and covalent docking approaches.
    Katritch V; Byrd CM; Tseitin V; Dai D; Raush E; Totrov M; Abagyan R; Jordan R; Hruby DE
    J Comput Aided Mol Des; 2007; 21(10-11):549-58. PubMed ID: 17960327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and evaluation of inhibitors for severe acute respiratory syndrome 3C-like protease based on phthalhydrazide ketones or heteroaromatic esters.
    Zhang J; Pettersson HI; Huitema C; Niu C; Yin J; James MN; Eltis LD; Vederas JC
    J Med Chem; 2007 Apr; 50(8):1850-64. PubMed ID: 17381079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs.
    Zhang XW; Yap YL
    Bioorg Med Chem; 2004 May; 12(10):2517-21. PubMed ID: 15110833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase inhibitors block MHV-3 induced apoptosis and enhance viral replication and pathogenicity.
    Leibowitz JL; Belyavskaya E
    Adv Exp Med Biol; 2001; 494():109-14. PubMed ID: 11774453
    [No Abstract]   [Full Text] [Related]  

  • 17. Citrinin hydrate and radicinin: human rhinovirus 3C-protease inhibitors discovered in a target-directed microbial screen.
    Kadam S; Poddig J; Humphrey P; Karwowski J; Jackson M; Tennent S; Fung L; Hochlowski J; Rasmussen R; McAlpine J
    J Antibiot (Tokyo); 1994 Jul; 47(7):836-9. PubMed ID: 8071130
    [No Abstract]   [Full Text] [Related]  

  • 18. Discovery of anti-SARS coronavirus drug based on molecular docking and database screening.
    Chen HF; Yao JH; Sun J; Li Q; Li F; Fan BT; Yuan SG
    Chin J Chem; 2004 Aug; 22(8):882-887. PubMed ID: 32313408
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.